Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Frier

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Diabetes|November 28, 2007
Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes: effect of impaired awareness of hypoglycemiaNicola N Zammitt, Roderick E Warren, Ian J Deary, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2007
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemiaAndrew J Sommerfield, Ian B Wilkinson, David J Webb, et al.
Alzheimer'S Research & Therapy|June 11, 2015
The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factorsInsa Feinkohl, Jackie F Price, Mark W J Strachan, et al.
Diabetes/Metabolism Research and Reviews|January 22, 2009
Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metforminJohn Y C Chan, Malgorzata Leyk, Brian M Frier, et al.
Diabetes/Metabolism Research and Reviews|January 6, 2017
Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapiesDavid C Klonoff, G Alexander Fleming, Douglas B Muchmore, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mLWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|June 27, 2018
Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitusBrian M Frier, Wolfgang Landgraf, Mei Zhang, et al.
Primary Care Diabetes|February 15, 2022
Diabetes and driving safety in India: The internet as a valuable source of informationAviral Chandel, Brian M Frier, Jana Urbanová, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Effects of acute hypoglycemia on motivation and cognitive interference in people with type 1 diabetesVincent McAulay, Ian J Deary, Andrew J Sommerfield, et al.
Primary Care Diabetes|May 4, 2023
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trialsWolfgang Landgraf, Gregory Bigot, Brian M Frier, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Diabetes|November 28, 2007
Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes: effect of impaired awareness of hypoglycemiaNicola N Zammitt, Roderick E Warren, Ian J Deary, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2007
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemiaAndrew J Sommerfield, Ian B Wilkinson, David J Webb, et al.
Alzheimer'S Research & Therapy|June 11, 2015
The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factorsInsa Feinkohl, Jackie F Price, Mark W J Strachan, et al.
Diabetes/Metabolism Research and Reviews|January 22, 2009
Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metforminJohn Y C Chan, Malgorzata Leyk, Brian M Frier, et al.
Diabetes/Metabolism Research and Reviews|January 6, 2017
Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapiesDavid C Klonoff, G Alexander Fleming, Douglas B Muchmore, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mLWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|June 27, 2018
Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitusBrian M Frier, Wolfgang Landgraf, Mei Zhang, et al.
Primary Care Diabetes|February 15, 2022
Diabetes and driving safety in India: The internet as a valuable source of informationAviral Chandel, Brian M Frier, Jana Urbanová, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Effects of acute hypoglycemia on motivation and cognitive interference in people with type 1 diabetesVincent McAulay, Ian J Deary, Andrew J Sommerfield, et al.
Primary Care Diabetes|May 4, 2023
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trialsWolfgang Landgraf, Gregory Bigot, Brian M Frier, et al.
Pageof 12